Roth/MKM Starts OS Therapies, Inc (OSTX) at Buy, PT $7, 'Durable Survival Supports OST-HER2 Approval'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street rises on revived AI momentum as earnings season picks up
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NYSE: OSTX) | Delayed: 1.27 +0.06 (4.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.21 | 52 Week High | $ | |||
| Open | $1.22 | 52 Week Low | $ | |||
| Day High | $1.28 | P/E | N/A | |||
| Day Low | $1.20 | EPS | $ | |||
| Volume | 248,364 | |||||
